Clinical Trial

Robotic-Enabled Microsurgical Intervention for Neurodegenerative Disease

Study acronym: REMIND
Recruiting
View on ClinicalTrials.gov →
Summary
The objective of this investigational device exemption (IDE) study is to evaluate the safety and feasibility of using the Symani System and microsurgical techniques in the deep cervical lymph node (dCLN) region in the setting of mild to moderate Alzheimer's disease and lymphatic abnormalities.
Protocol Amendment History 2 changes
notable Primary completion pushed: 2026-08-31 -> 2026-10-30 2026-06-03
minor Completion pushed: 2027-08-31 -> 2027-10-30 2026-06-03
Trial Details
NCT Number NCT07178210
Lead Sponsor MMI (Medical Microinstruments, Inc.)
Conditions Alzheimer Disease, Lymphatic Obstruction
Enrollment 15 participants
Start Date 2026-04-30
Primary Completion 2026-10-30 (estimated)
Study Completion 2027-10-30 (estimated)
Updated on ClinicalTrials.gov 2026-06-02